Quarterly Report III 11/12
September 2011 – May 2012Quarterly Report Diamyd Medical AB (publ), fiscal year 2011/2012(www.omxgroup.com ticker: DIAM B; www.otcqx.com ticker: DMYDY) Reporting period March 1, 2012 – May 31, 2012 · Group net sales amounted to MSEK 0.3 (19.5) · Loss before tax amounted to MSEK -1.9 (-43.6) · Earnings per share after dilution were SEK -0.1 (-1.5) · The Group’s liquid assets and short term investments amounted to MSEK 389 (442) as of May 31, 2012 Period September 1, 2011 – May 31, 2012 · Group net sales amounted to MSEK 1.0 (278.5) · Loss before tax amounted to